← Open Payments lookup

JANEFRANCES EZIMORAH: Open Payments

NPI 1104073303 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,277 in 43 payments from 11 companies in 2025. Trend: 2023 $1,420 · 2024 $1,020 · 2025 $1,277

Food & beverage: $1,277
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$357
ABBVIE INC.10$279
Lundbeck LLC14$238
Neurocrine BioSciences, Inc.1$140
Alkermes, Inc.4$76
Supernus Pharmaceuticals, Inc.4$70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Takeda Pharmaceuticals U.S.A., Inc.1$22
Bausch Health US, LLC1$22
Teva Pharmaceuticals USA, Inc.1$20

Products named: VRAYLAR, ABILIFY MAINTENA, REXULTI, INGREZZA, ABILIFY ASIMTUFII, ARISTADA, Qelbree, CAPLYTA.

Industry payments across MD — which companies pay providers there.